Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Objective To determine the degree of variation in mortality and major mornidity following trasurethral resection of the prostate (TURP), and to assess intersite variation for mortality and morbidity over 12 sites within the Northern Region. Further, to determine whether the previously observed effects on morbidity of unit size, patient through‐put and emergency admission were borne out in contemporary urological practice in the Northern Region. Patients and methods For an 8 month period, 1 April 1991‐31 Novemebr 1991, an independent audit of TUROP was performed on 12 different hospital sites throughout the Northern Region. a constant data set was designed which was collected on each patient before and 3 months after operation by two independent clinical co‐ordinators who travelled to each of the sites. All case notes were reviewes at 3 months after operation by two independent clinical co‐ordinators who travelled to each of the sites. All case notes were reviewes at 3 months after operation by the co‐ordinators using a standard proforma, rather than depending upon self reporting by medical staff. Fata on factors potentially affecting mortality and morbidity were collected, including emergency admission, diagnosis of prostate cancer, American Society of Anesthesiologists co‐morbidity scores, and age and differences in though‐put in the 12 sites. The effect of through‐put or ‘volume’ on mortality and morbidity was assessed by comparing morbidity and the number of cases performed. Results The early mean death rate was 13 of 1396 patients (0.9%) with an inter‐site variation ranging from 0% to 3.8%. a mean of 2.0% of men were returned to theatre after TURP, 2.4% of parients received a blood transfusion ( > 2 units) after operation, and 8.0% of patients developed post‐operative sepsis; these complications varied sixfold, sevenfold and 17 fold across the different sites respectively. Those units performing ≤ 100 operations over the audit period (equivalent to < 150 operation per year) had a significantly increased rate of deaths and complications which was not related to population differences. though some low volume units had good results. Elderly men who were particularly vulnerable to comlications. Conclusions The overall early mortality rate after TURP for benign prostatic hyperpalsia across the Region compares well with other reported large series. The significant variantion in morbidity rates found in this study suggests that careful attention needs to be paid by Urologists, Purchasers and Providers to morbidity rates after prostatectomy. © 1994 BJU International Company

Original publication

DOI

10.1111/j.1464-410X.1994.tb09184.x

Type

Journal article

Journal

British Journal of Urology

Publication Date

01/01/1994

Volume

74

Pages

559 - 565